Myelodysplastic syndrome and aplastic anemia: Distinct entities or diseases linked by a common pathophysiology?
- 1 January 2000
- journal article
- review article
- Published by Elsevier in Seminars in Hematology
- Vol. 37 (1) , 15-29
- https://doi.org/10.1016/s0037-1963(00)90027-1
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Overexpression of tumor necrosis factor (TNF)-α and interferon (IFN)-γ by bone marrow cells from patients with myelodysplastic syndromesLeukemia, 1997
- T-cell Receptor β Chain Variability in Bone Marrow and Peripheral Blood in Severe Acquired Aplastic AnemiaBlood Cells, Molecules, and Diseases, 1997
- Analysis of T‐cell clonality in bone marrow of patients with acquired aplastic anaemiaBritish Journal of Haematology, 1997
- Could aplastic anaemia be considered a pre‐pre‐leukaemic disorder?European Journal of Haematology, 1996
- Hypocellular myelodysplastic syndromes (MDS): new proposalsBritish Journal of Haematology, 1995
- Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemiaBritish Journal of Haematology, 1995
- Clonal analysis of peripheral blood and haemopoietic colonies in patients with aplastic anaemia and refractory anaemia using the polymorphic short tandem repeat on the human androgen‐receptor (HUMARA) geneBritish Journal of Haematology, 1995
- T cell‐mediated inhibition of erythropoiesis in myelodysplastic syndromesAmerican Journal of Hematology, 1992
- Letter to the editor: Low‐dose cyclosporin for severe aplastic anemiaAmerican Journal of Hematology, 1992
- Cyclosporine in Refractory Severe Aplastic AnemiaNew England Journal of Medicine, 1984